Clinical Trials Overview
We are devoted to discovering and developing medicines that reduce suffering and improve the lives of patients with the most difficult-to-treat cancers. As part of that process, we must conduct clinical trials to establish their efficacy, safety and tolerability to gain approval from regulatory agencies in the United States and around the world.
Patient participation in clinical trials is important. If you are chosen to enroll in one of our trials, you will be participating in important health research and helping to advance the scientific understanding of cancer.
Read more to see where our clinical trial sites are located and the types of cancer for which we are evaluating our investigational medicines.
Find Clinical Trials Near Me
|Study Phase||Cancer Type(s)||Investigational Medicine||Status|
|Phase 1b||Renal cell carcinoma (RCC)||CPI-444 + atezolizumab||Enrolling||More Info|
|Phase 1b/2 (MORPHEUS)*||Non-small cell lung cancer (NSCLC)||CPI-444 + atezolizumab||Enrolling||More Info|
|Phase 1/1b||NSCLC, RCC, other solid tumors||CPI-006
CPI-006 + CPI-444
CPI-006 + pembrolizumab
*Conducted by Genentech.
For more information on our product candidates, please see our Annual Report available in the SEC Filings section of the website.